Drug Trial Radar · NCT06857955
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
396
Actual
Start
Mar 26, 2025
Primary completion
Sep 17, 2026
Study completion Apr 5, 2028
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy, safety and tolerability of QCZ484 or placebo, given subcutaneously, every 6 months, at different dose levels in patients with mild to moderate hypertension
Conditions
- Hypertension
Interventions
SalineOther
0.9% sodium chloride saline solution
QCZ484Drug
Solution of Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Mean 24hr SBP by ABPMTime frame: Baseline, Month 3
Locations
72 sites in 3 countries. Site status is shown where the registry gives one.
SEC Clinical Research LLC
Andalusia, Alabama
Longwood Research
Huntsville, Alabama
The Center for Clinical Trials
Saraland, Alabama
Elite Clinical Studies
Phoenix, Arizona
Synexus Clinical Research US Inc
Tucson, Arizona
NICRs Research Center
Garden Grove, California
Valiance Clinical Research
Huntington Park, California
Downtown L A Research Center Inc
Los Angeles, California
Headlands Research Sacramento
Sacramento, California
Encompass Clinical Research
Spring Valley, California
Clinical Research of Brandon LLC
Brandon, Florida
ALL Medical Research LLC
Cooper City, Florida
National Research Institute
Hialeah, Florida
Cen Exel RCA
Hollywood, Florida
East Coast Institute for Research
Jacksonville, Florida
Entrust Clinical Research
Miami, Florida
Inpatient Research Clinical LLC
Miami Lakes, Florida
Renstar Medical Research
Ocala, Florida
American Research Centers of FL
Pembroke Pines, Florida
Cen Exel FCR
Tampa, Florida
Cardiology Partners Clinical Research Institute
Wellington, Florida
Centricity Research
Columbus, Georgia
Javara Research
Fayetteville, Georgia
Velocity Clinical Research
Savannah, Georgia
Solaris Clinical Research
Meridian, Idaho
Cedar Crosse Research Ct
Chicago, Illinois
Eagle Clinical Research
Chicago, Illinois
Synexus Clinical Research US
Evansville, Indiana
Velocity Clin Research Sioux City
Sioux City, Iowa
Alliance for Multispecialty Research
Wichita, Kansas
Velocity Clinical Res Baton Rouge
Baton Rouge, Louisiana
Southern Clin Research Clinic
Zachary, Louisiana
Ascension Saint Agnes Heart Care
Baltimore, Maryland
Anderson Medical Research
Ft. Washington, Maryland
Capitol Cardiology Associates
Lanham, Maryland
AA Medical Research Center
Flint, Michigan
Oakland Medical Research Center
Troy, Michigan
Synexus Clinical Research US Inc
Richfield, Minnesota
Healthcare Research Network II LLC
Hazelwood, Missouri
Jefferson City Medical Group
Jefferson City, Missouri
Showing 40 of 72 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.